secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K/A
Filed at:   2024-04-10T23:59:59+00:00
Accession:  0001493152-24-014240
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio raises $6.0M via Series A-1 Preferred Stock sale to existing investor
--------------------------------------------------------------------------------

- Sold 600 shares of Series A-1 Preferred at $10,000/share to Patel Family, LLP, affiliated with >5% holder Dr. Manmohan Patel.
- Preferred converts into 600,000 common shares; carries 5% cumulative dividend, increasing 2%/yr, max 15%.
- Company has call right to redeem at $10,000 plus accrued dividends if 20-day VWAP exceeds $5.00 and registration effective.
- Series A-1 Preferred ranks pari passu with Series A Pref and senior to common and Series B on liquidation.
- Amendment corrects omission of Item 3.02 disclosure; original filing on March 27, 2024 is restated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/0001493152-24-014240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224014240/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer